Systematic review: maintenance treatment of gastro‐oesophageal reflux disease with proton pump inhibitors taken ‘on‐demand’

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2007.03381.xPMID 17593065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On-Demand Therapy for Gastroesophageal Reflux Disease

  2007cited by this paper
• Pretreatment Endoscopy - Pro & Contra: Is Endoscopy Needed before Treatment in All Patients with Gastroesophageal Reflux Disease?

  2006cited by this paper
• Pretreatment endoscopy--pro & contra: endoscopy is needed before treatment in all patients with gastroesophageal reflux disease.

  2006cited by this paper
• Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease

  2006cited by this paper
• Gastro-oesophageal reflux disease.

  2006cited by this paper
• High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report

  2005cited by this paper
• Treatment of patients with heartburn without endoscopic evaluation: on‐demand treatment after effective continuous administration of lansoprazole 15 mg

  2005cited by this paper
• Systematic review: the efficacy of intermittent and on‐demand therapy with histamine H2‐receptor antagonists or proton pump inhibitors for gastro‐oesophageal reflux disease patients

  2005cited by this paper
• The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis.

  2005cited by this paper
• Daily treatment with esomeprazole is superior to that taken on‐demand for maintenance of healed erosive oesophagitis

  2005cited by this paper
• On-Demand Therapy with Pantoprazole 20 mg as Effective Long-Term Management of Reflux Disease in Patients with Mild GERD: The ORION Trial

  2005cited by this paper
• A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease

  2005cited by this paper
• Six‐month management of patients following treatment for gastroesophageal reflux disease symptoms – a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting

  2005cited by this paper
• Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease

  2005cited by this paper
• Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group

  2005cited by this paper
• Quality of life in acute and maintenance treatment of non‐erosive and mild erosive gastro‐oesophageal reflux disease

  2005cited by this paper
• Long‐term treatment of gastro‐oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on‐demand treatment compared with continuous treatment

  2005cited by this paper
• From the authors

  2005cited by this paper
• Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

  2005cited by this paper
• Esomeprazole 20 mg on‐demand is more acceptable to patients than continuous lansoprazole 15 mg in the long‐term maintenance of endoscopy‐negative gastro‐oesophageal reflux patients: the COMMAND Study

  2004cited by this paper
• Les nouveaux inhibiteurs de la pompe à protons, un progrès dans la prise en charge des maladies acido-peptiques ?

  2004cited by this paper
• On-Demand Therapy with Rabeprazole in Nonerosive and Erosive Gastroesophageal Reflux Disease in Clinical Practice: Effectiveness, Health-Related Quality of Life, and Patient Satisfaction

  2004cited by this paper
• Effectiveness of proton pump inhibitors in nonerosive reflux disease.

  2004cited by this paper
• Six‐month trial of on‐demand rabeprazole 10 mg maintains symptom relief in patients with non‐erosive reflux disease

  2004cited by this paper
• On-demand PPI Requirements in Patients With Endoscopy-Negative GERD

  2004cited by this paper
• Costs and efficacy of three different esomeprazole treatment strategies for long‐term management of gastro‐oesophageal reflux symptoms in primary care

  2004cited by this paper
• [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].

  2004cited by this paper
• Gastroesophageal Reflux Disease: A Typical Spectrum Disease (A New Conceptual Framework is Not Needed)

  2004cited by this paper
• Systematic review: is there excessive use of proton pump inhibitors in gastro‐oesophageal reflux disease?

  2004cited by this paper
• Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.

  2002cited by this paper
• Gastroesophageal reflux disease—should we adopt a new conceptual framework?

  2002cited by this paper
• Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

  2002cited by this paper
• On-Demand Treatment in Patients with Oesophagitis and Reflux Symptoms: Comparison of Lansoprazole and Omeprazole

  2002cited by this paper
• Esomeprazole 20 mg maintains symptom control in endoscopy‐negative gastro‐oesophageal reflux disease: a controlled trial of ‘on‐demand’ therapy for 6 months

  2001cited by this paper
• On demand therapy with omeprazole for the long‐term management of patients with heartburn without oesophagitis—a placebo‐controlled randomized trial

  1999cited by this paper
• Factors influencing compliance in long-term proton pump inhibitor therapy in general practice.

  1999cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.

  1997cited by this paper
• Gastroesophageal reflux disease.

  1996cited by this paper

• Esophageal Disorders in the Older Adult

  2025cites this paper
• Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.

  2025cites this paper
• Comprehensive Benefit Evaluation and Clinical Decision-Making After 4-week Cinitapride Treatment on Functional Dyspepsia: A Multicenter, Prospective Designed, Real-World Study.

  2025cites this paper
• Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología.

  2024cites this paper
• Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología

  2024cites this paper
• S2k guideline Gastroesophageal reflux disease and eosinophilic esophagitis of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)

  2024cites this paper
• Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial

  2023influential citation
• On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter Study

  2023cites this paper
• Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

  2023cites this paper
• S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013

  2023cites this paper
• Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study

  2023cites this paper
• Abordaje terapéutico de la enfermedad por reflujo gastroesofágico

  2022cites this paper
• Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021

  2022cites this paper
• AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.

  2022cites this paper
• GASTROESOPHAGEAL REFLUX DISEASE: A PRACTICAL APPROACH.

  2021cites this paper
• ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

  2021cites this paper
• Diagnostic work up and indications for gastro-esophageal reflux surgery

  2020cites this paper
• Addressing long-term PPI safety.

  2020cites this paper
• Factors associated with the use of gastrointestinal medicines amoung older people with intellectual disabilities in Ireland

  2020cites this paper
• Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease

  2020cites this paper
• Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients

  2020cites this paper
• API-ISG Consensus Guidelines for Management of Gastrooesophageal Reflux Disease.

  2020cites this paper
• Medical Management of LPR

  2019cites this paper
• Medical Management of GERD

  2019cites this paper
• Laryngopharyngeal Reflux Disease

  2019influential citation
• Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology

  2019cites this paper
• The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study

  2018cites this paper
• Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders

  2018cites this paper
• On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis

  2018cites this paper
• Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

  2018cites this paper
• Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials

  2018cites this paper
• Efficacy of On-Demand Therapy Using 20-mg Vonoprazan for Mild Reflux Esophagitis

  2018cites this paper
• The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.

  2018cites this paper
• Strategies for Effective Discontinuation of Proton Pump Inhibitors

  2018cites this paper
• Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole

  2018cites this paper
• Diagnosis and treatment of gastroesophageal reflux disease : recommendations of the Asociación Mexicana

  2018cites this paper
• Réduction d’un traitement chronique par inhibiteur de la pompe à protons, possible ?

  2018cites this paper
• 8 COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H 2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

  2018cites this paper
• On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease

  2018cites this paper
• Proton pump inhibitors

  2017cites this paper
• The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

  2017cites this paper
• Traitement du reflux gastro-œsophagien de l’adulte

  2017cites this paper
• Reflux Esophagitis and the Child with Heartburn

  2017cites this paper
• Рекомендации Российской гастроэнтерологической ассоциациии Ассоциации колопроктологов России по диагностике и лечению взрослых больных дивертикулярной болезнью ободочной кишки

  2016cites this paper
• iagnosis and treatment of gastroesophageal reflux isease : recommendations of the Asociación Mexicana e Gastroenterología

  2016cites this paper
• Long-Term PPI Use: Balancing Potential Harms and Documented Benefits

  2016cites this paper
• 25 Years of Proton Pump Inhibitors: A Comprehensive Review

  2016cites this paper
• Diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico: recomendaciones de la Asociación Mexicana de Gastroenterología

  2016cites this paper
• Diagnosis and treatment of gastroesophageal reflux disease: recommendations of the Asociación Mexicana de Gastroenterología.

  2016cites this paper
• Gastroesophageal Reflux Disease

  2016cites this paper
• Consenso mexicano de enfermedad por reflujo gastroesofágico. Parte I

  2016cites this paper
• Proton Pump Inhibitors: The Perils of Turning 30

  2016cites this paper
• Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

  2016cites this paper
• Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease

  2016cites this paper
• Clinical Practice Guidelines on the Diagnosis and Treatment of Gastroesophageal Reflux Disease (GERD)

  2015cites this paper
• Association between vitamin B12 deficiency and long‐term use of acid‐lowering agents: a systematic review and meta‐analysis

  2015cites this paper
• Challenges of Correlating pH Change with Relief of Clinical Symptoms in Gastro Esophageal Reflux Disease: A Phase III, Randomized Study of Zegerid versus Losec

  2015cites this paper
• Review of Proton Pump Inhibitor Overuse in the US Veteran Population

  2015cites this paper
• 2. Zielorientierung der Leitlinie

  2014cites this paper
• S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

  2014cites this paper
• Proton Pump Inhibitors: The Perils of Turning 30

  2014cites this paper
• [S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013].

  2014cites this paper
• Proton Pump Inhibitors in Gastroesophageal Reflux Disease

  2013cites this paper
• Gastroesophageal Reflux Disease

  2013cites this paper
• Corrigendum: Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease

  2013cites this paper
• Clinical Practice Guideline For the Diagnosis and Management of Gastroesophageal Reflux Disease

  2013cites this paper
• Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.

  2013cites this paper
• Implications of Over-the-Counter Proton Pump Inhibitors for Patient Counseling by Pharmacists

  2013cites this paper
• Patient Selection for Therapy Reduction after Long-Term Daily Proton Pump Inhibitor Treatment for Gastro-Oesophageal Reflux Disease: Trial and Error

  2013cites this paper
• Corrigendum: Diagnostic Testing in Extraesophageal GERD: Another Case of “Furor Medicus”?

  2013cites this paper
• The efficacy, safety and cost‐effectiveness of hydrotalcite versus esomeprazole in on‐demand therapy of NERD: A multicenter, randomized, open‐label study in China

  2013cites this paper
• Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro‐oesophageal reflux disease

  2013cites this paper
• [Updated guidelines 2012 for gastroesophageal reflux disease].

  2012cites this paper
• Esomeprazole

  2012cites this paper
• Quality improvement in action Glad you brought it up: a patient-centred programme to reduce proton-pump inhibitor prescribing in general medical practice

  2012cites this paper
• Medical therapy of GERD and NERD The severity of symptoms does not correlate with the presence or with severity of subtypes of GERD (

  2012cites this paper
• Treatment of GERD

  2012cites this paper
• A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori-Negative Primary Care Patients with Dyspepsia in Japan

  2012cites this paper
• Alternative therapeutic approaches to chronic proton pump inhibitor treatment.

  2012cites this paper
• Guide to the Use of Proton Pump Inhibitors in Adult Patients

  2012cites this paper
• Long-term medical management of gastro-esophageal reflux disease: how long and when to consider surgery?

  2012cites this paper
• [The Mexican consensus on gastroesophageal reflux disease. Part I].

  2012cites this paper
• Proton pump inhibitors in gastroesophageal reflux disease: "a custom-tailored therapeutic regimen".

  2012cites this paper
• INGUINAL AND MESENTERIC LYMPH NODES IN CONDITIONS OF GROWTH OF EXPERIMENTAL MALIGNANT TUMOR IN THE RECTUM

  2012cites this paper
• Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review.

  2012cites this paper
• Konservative Therapie: Lebenswandeländerung, Antazida, H2-Blocker oder doch nur Protonenpumpeninhibitoren?

  2011cites this paper
• A health insurance company-initiated practice support intervention for optimizing acid-suppressing drug prescriptions in primary care

  2011cites this paper
• Traitement du reflux gastro-œsophagien de l'adulte

  2011cites this paper
• Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

  2011cites this paper
• Review of proton pump inhibitors for the initial treatment of heartburn: Is there a dose ceiling effect?

  2011cites this paper
• Postoperative recurrence factors of GERD in the elderly after laparoscopic fundoplication

  2010cites this paper
• Drug therapy of gastroesophageal reflux disease: Good treatment strategies in Korea and recently developed drugs

  2010cites this paper
• 2. Gastroesophageal Reflux Disease

  2010cites this paper
• A health insurance company-initiated multifaceted intervention for optimizing acid-suppressing drug prescriptions in primary care: a randomized controlled trial.

  2010cites this paper
• Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?

  2010cites this paper
• Maintenance therapy of gastroesophageal reflux disease

  2010cites this paper
• Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.

  2009cites this paper
• Is the course of gastroesophageal reflux disease progressive? A 21-year follow-up

  2009cites this paper
• Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines

  2009cites this paper
• Gastroesophageal Reflux Disease: Medical or Surgical Treatment?

  2009cites this paper